EcoDrugPlus

Melanoma Receptor Tyrosine-Protein Kinase-Like

Ensembl ID : ENSXMAG00000024953
Gene Symbol: LOC111606142
2 Cross references
213 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSXMAG00000021449
Gene Symbol: MTNR1A
3 Cross references
186 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSXMAG00000001538
Gene Symbol: MME
4 Cross references
224 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSXMAG00000001572
Gene Symbol: MME
4 Cross references
199 Possible Orthologues:

Metabotropic Glutamate Receptor 2-Like

Ensembl ID : ENSXMAG00000016335
Gene Symbol: LOC102217242
3 Cross references
206 Possible Orthologues:

Metabotropic Glutamate Receptor 3-Like

Ensembl ID : ENSXMAG00000004218
Gene Symbol: LOC102237526
3 Cross references
215 Possible Orthologues:

Metabotropic Glutamate Receptor 5-Like

Ensembl ID : ENSXMAG00000017676
Gene Symbol: LOC102230735
3 Cross references
211 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSXMAG00000015392
Gene Symbol: METAP2
4 Cross references
220 Possible Orthologues:

Microtubule-Associated Protein Tau

Ensembl ID : ENSXMAG00000017005
Gene Symbol: LOC102225585
2 Cross references
205 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSXMAG00000006444
Gene Symbol: MAPK1
3 Cross references
211 Possible Orthologues:

Mitogen-Activated Protein Kinase 1-Like

Ensembl ID : ENSXMAG00000024764
Gene Symbol: LOC102237032
3 Cross references
197 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSXMAG00000004480
Gene Symbol: MAPK10
3 Cross references
88 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).